{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T17:31:26Z","timestamp":1766683886247,"version":"3.48.0"},"reference-count":19,"publisher":"BMJ","issue":"7176","license":[{"start":{"date-parts":[[1999,1,9]],"date-time":"1999-01-09T00:00:00Z","timestamp":915840000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.bmj.com\/company\/legal-information\/terms-conditions\/legal-information\/tdm-licencepolicy"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMJ"],"published-print":{"date-parts":[[1999,1,9]]},"DOI":"10.1136\/bmj.318.7176.106","type":"journal-article","created":{"date-parts":[[2011,10,27]],"date-time":"2011-10-27T19:56:26Z","timestamp":1319745386000},"page":"106-109","source":"Crossref","is-referenced-by-count":37,"title":["Drug treatment of epilepsy"],"prefix":"10.1136","volume":"318","author":[{"given":">Morgan","family":"Feely","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[1999,1,9]]},"reference":[{"key":"2025122509283521000_318.7176.106.1","first-page":"2223","article-title":"The epilepsies and convulsive disorders","volume-title":"Harrison's principles of internal medicine.","volume":"Vol 2","author":"Dichter","year":"1994"},{"key":"2025122509283521000_318.7176.106.2","unstructured":"Richens A Perucca E .General principles in the drug treatment of epilepsy. In: A textbook of epilepsy. 4th ed. Edinburgh: Churchill Livingstone,1993."},{"key":"2025122509283521000_318.7176.106.3","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1059-1311(97)80001-5","article-title":"Established antiepileptic drugs.","volume":"6","author":"Brodie","year":"1997","journal-title":"Seizure"},{"key":"2025122509283521000_318.7176.106.4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1994.tb02448.x"},{"key":"2025122509283521000_318.7176.106.5","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1059-1311(98)80068-X","article-title":"Prescribing of anti-epileptic drugs in the northern and Yorkshire region 1992-1995.","volume":"7","author":"Roberts","year":"1998","journal-title":"Seizure"},{"key":"2025122509283521000_318.7176.106.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199606133342407"},{"key":"2025122509283521000_318.7176.106.7","first-page":"98","article-title":"New drug treatments for epilepsy.","volume":"38","author":"Stephen","year":"1998","journal-title":"Prescribers J"},{"key":"2025122509283521000_318.7176.106.8","first-page":"95","article-title":"A multicentre study of vigabatrin for drug-resistant epilepsy.","volume":"27","author":"Brown","year":"1989","journal-title":"Br J Clin Pharmacol"},{"key":"2025122509283521000_318.7176.106.9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)90581-2"},{"key":"2025122509283521000_318.7176.106.10","first-page":"114","article-title":"Gabapentin in partial epilepsy.","volume":"335","year":"1990","journal-title":"Lancet"},{"key":"2025122509283521000_318.7176.106.11","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1212\/WNL.43.11.2292","article-title":"Gabapentin as add-on therapy in refractory partial epilepsy.","volume":"43","year":"1993","journal-title":"Neurology"},{"key":"2025122509283521000_318.7176.106.12","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1212\/WNL.46.6.1684","article-title":"Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200, 400 and 600 mg daily dosages.","volume":"46","author":"Faught","year":"1996","journal-title":"Neurology"},{"key":"2025122509283521000_318.7176.106.13","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1136\/bmj.313.7066.1169","article-title":"New antiepileptic drugs: a systematic review of their efficacy and tolerability.","volume":"313","author":"Marson","year":"1996","journal-title":"BMJ"},{"key":"2025122509283521000_318.7176.106.14","first-page":"S41","article-title":"Lamotrigine versus other antiepileptic drugs: a star rating system is born.","volume":"35","author":"Brodie","year":"1994","journal-title":"Epilepsia"},{"key":"2025122509283521000_318.7176.106.15","first-page":"1","article-title":"Vigabatrin (Sabril) and visual field defects.","volume":"24","year":"1998","journal-title":"Curr Probl Pharmacovigilence"},{"key":"2025122509283521000_318.7176.106.16","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.47.12.1279"},{"key":"2025122509283521000_318.7176.106.17","unstructured":"British Epilepsy Association .The treatment of epilepsy\u2014a patient's viewpoint (survey results). Leeds: British Epilepsy Association,1996."},{"key":"2025122509283521000_318.7176.106.18","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJM199209103271104","article-title":"A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalised tonic-clonic seizures.","volume":"327","author":"Mattson","year":"1992","journal-title":"N Engl J Med"},{"key":"2025122509283521000_318.7176.106.19","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)90074-4"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj.318.7176.106","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.318.7176.106","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T17:28:45Z","timestamp":1766683725000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.318.7176.106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,1,9]]},"references-count":19,"journal-issue":{"issue":"7176","published-online":{"date-parts":[[1999,1,9]]},"published-print":{"date-parts":[[1999,1,9]]}},"alternative-id":["10.1136\/bmj.318.7176.106"],"URL":"https:\/\/doi.org\/10.1136\/bmj.318.7176.106","relation":{},"ISSN":["0959-8138","1468-5833"],"issn-type":[{"type":"print","value":"0959-8138"},{"type":"electronic","value":"1468-5833"}],"subject":[],"published":{"date-parts":[[1999,1,9]]}}}